In a recent study published in JAMA, researchers evaluated the efficacy and safety of zilebesiran doses in reducing mild to moderate hypertension. Study: RNA Interference With Zilebesiran for Mild to ...

Cancer is a general term that encompasses different subtypes of abnormal cellular growth in different areas of the body. One such type of cancer is the uncontrollable proliferation of skin cells known ...

A particular protein deficiency that leads to liver and lung damage is currently treatable only with decades-old therapies that all have limitations. Biotech startup AIRNA is part of a field of ...

Nearly 1.3 billion adults around the world have clinically high blood pressure, many of whom may be unaware that they are living with this condition. Nearly 1.3 billion adults around the world have ...

Cow’s milk contains nanoparticles that can be used to deliver disease-modifying RNA therapy orally, according to a new study. With RNA-based drugs currently only administrable by injection, the ...

RNA therapies are emerging as a promising treatment for cancer, but some types of the disease don’t respond well to it. Now, scientists at Tel Aviv University have demonstrated a way to use RNA drugs ...

A developer of RNA editing therapies whose lead program targets Alpha-1 antitrypsin deficiency (AATD) said today it has closed an oversubscribed $60 million Series A financing, with plans that include ...

An experimental RNA therapy from Avidity Biosciences has early clinical trial results showing it reduced by half the expression of a gene at the root of a rare, inherited form of muscular dystrophy ...

The ability to control the expression of therapeutic genes within a “therapeutic window” is crucial to ensure the development of safe and effective gene therapies, but to date, there has been no ...

Lipid-based nanoparticles are a popular research area as a non-viral platform for delivering RNA molecules and include liposomes, lipoplexes, lipid nanoparticles and solid lipid nanoparticles. Using ...